iMER

Company Overview

Snapshot

Founded in January 2005 by Ilan Tamir, iMER operates with 11–50 employees. The company has raised $7 million across one funding round from Viola Growth. In February 2013, iMER secured its funding round.

Business overview

iMER is a global health service provider offering a comprehensive framework of medical services for international patients. The company addresses challenges such as incorrect diagnoses, the need for second medical opinions, or the requirement for specialized treatments unavailable in a patient's home country. iMER facilitates interactions between medical specialists for case assessment, diagnosis, and treatment planning through tele-conference, video-conference, or its proprietary telemedicine platform, iPMS. It operates within the Digital Healthcare sector, focusing on medical decision support and digital medical diagnostics.

Strategic signal

In February 2013, iMER raised $7 million, a significant capital injection that enabled the company to further develop its international medical evaluation and referral services. This funding underscored investor confidence in iMER's model for connecting patients with specialized medical expertise globally, signaling a validation of its telemedicine platform and cross-border healthcare approach.

Company Intelligence Q&A

When was iMER founded?

iMER was founded in January 2005 by Ilan Tamir.

What is iMER's primary offering?

iMER provides an independent, global health service framework for comprehensive medical services, including second opinions and specialized treatments, for patients worldwide.

What is the name of iMER's telemedicine platform?

iMER coordinates medical consultations and treatment planning through its telemedicine platform, iPMS.

Which investor participated in iMER's funding round?

In February 2013, iMER raised $7 million in a funding round, with participation from Viola Growth.

What is iMER's status as of January 2016?

iMER's status was Non Active as of January 2016.